Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Neurology
Glioblastoma multiforme Clinical Trials
A listing of Glioblastoma multiforme medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Arkansas
Little Rock : University of Arkansas for Medical Sciences Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
California
Duarte : City of Hope Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Irvine : UCI Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
La Jolla : University of California San Diego Moores Cancer Center (UCSD) Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
La Jolla : UCSD Moores Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Los Angeles : Research Site
AMG 595 First-in-Human in Recurrent Gliomas
View More »
Los Angeles : University of California, Los Angeles
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Los Angeles : University of Southern California (USC) Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Los Angeles : UCLA Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Los Angeles : UCLA Updated
Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Los Angeles : UCLA Neuro-Oncology Program
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Newport Beach : Hoag Memorial Hospital Presbyterian Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Orange : St. Joseph Hospital of Orange Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Sacramento : Sutter Institute for Medical Research Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
San Diego : University of California at San Diego Updated
Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
San Francisco : University of California at San Francisco
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
San Francisco : University of California at San Francisco
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
South Pasadena : South Pasadena Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Colorado
Aurora : University of Colorado Denver Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Aurora : University of Colorado Denver, University of Colorado Cancer Center
Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme
Aurora : University of Colorado Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Connecticut
New Haven : Yale School of Medicine
Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Florida
Fort Myers : Florida Cancer Specialists
Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Miami Beach : Mount Sinai CCOP Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Orlando : Florida Hospital Cancer Institute
Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Orlando : MD Anderson Cancer Center Orlando Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Pensacola : Woodlands Medical Specialists
Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
View More »
Sarasota : Florida Cancer Specialists
Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma or Progressive Secondary Brain Tumor
Tampa : H. Lee Moffitt Cancer Center & Research Institute Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Tampa : Moffitt Cancer Center & Research Institute
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Georgia
Atlanta : Emory University, Winship Cancer Institute Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Illinois
Chicago : Northwestern University Feinberg School of Medicine
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Chicago : University of Illinois at Chicago (UIC) Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Chicago : Rush University Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Chicago : University of Illinois Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Chicago : Northwestern University - Robert H Lurie Comprehensive Cancer Center
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
View More »
Peoria : Illinois Cancer Care Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Indiana
Indianapolis : IU Simon Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Kansas
Westwood : University of Kansas Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Kentucky
Lexington : University of Kentucky, Markey Cancer Center Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Lexington : University of Kentucky - Markey Cancer Center
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Louisville : Norton Cancer Institute Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Maine
Scarborough : Maine Medical Center Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Maryland
Baltimore : The Johns Hopkins Hospital Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Bethesda : Center for Cancer and Blood Disorders
Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Massachusetts
Boston : Massachusetts General Hosptial
Amgen 386 for Recurrent Glioblastoma
Boston : Dana-Farber Cancer Institute
Amgen 386 for Recurrent Glioblastoma
Boston : Tufts Medical Center Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Boston : Massachusetts General Hospital
PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
Boston : Dana-Farber Cancer Institute
PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
View More »
Boston : Tufts Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Burlington : Lahey Clinic Medical Center Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Michigan
Ann Arbor : University of Michigan, Department of Neurosurgery Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Detroit : Henry Ford Health Systems
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Detroit : Henry Ford Health System Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Detroit : Henry Ford Hospital
PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
Detroit : Henry Ford Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
View More »
Detroit : Henry Ford Hospital Updated
Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Minnesota
Minneapolis : John Nasseff Neuroscience Institute Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Missouri
Chesterfield : St. Louis Cancer Care
Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Kansas City : St. Luke's Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
St. Louis : Washington University School of Medicine, Division of Oncology Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
St. Louis : Washington University School of Medicine Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Nebraska
Omaha : Nebraska Methodist Hospital
Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
New Jersey
Edison : New Jersey Neuroscience Center - JFK Medical Center Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Edison : JFK Medical Center Updated
Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Hackensack : John Theurer Cancer Center at Hackensack University Medical Center Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Hackensack : John Theurer Cancer Center at Hackensack University Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Hackensack : John Theurer Cancer Center at Hackensack University
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
View More »
Summit : Overlook Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New York
Manhasset : Biomedical Research Alliance of New York
Glioblastoma Multiforme (Brain Cancer) - Adults
Manhasset : Biomedical Research Alliance of New York
If you have a brain tumor, you may be eligible to participate in a research study being conducted by North Shore-Long Island Jewish Health System.
View More »
Huntington : Huntington Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Lake Success : Long Island Brain Tumor Centre at Neurological Surgery P.C. Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Lake Success : North Shore - Long Island Jewish Hospital/Monter Cancer Center
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Manhasset : North Shore University Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Mineola : Winthrop University Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New York : New York - Presbyterian/Columbia University Medical Center
Amgen 386 for Recurrent Glioblastoma
New York : Mount Sinai Medical Center, Department of Neurosurgery Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
New York : Columbia University Medical Center Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
New York : Weill Cornell Medical College Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
New York : The New York Hospital/ Weill Medical College
Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
New York : Columbia University Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New York : NYU Cancer Institute
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Oceanside : South Nassau Community Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Rochester : University of Rochester Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Rockville Centre : Mercy Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
White Plains : Brain and Spine Surgeons of New York and Northern Westchester Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
North Carolina
Chapel Hill : University of North Carolina Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Durham : The Preston Robert Tisch Brain Tumor Center
AMG 102 and Avastin for Recurrent Malignant Glioma
Durham : Duke University Medical Center
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Winston-Salem : Derrick L Davis Forsyth Regional Cancer Center
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Ohio
Cincinnati : Research Site
AMG 595 First-in-Human in Recurrent Gliomas
Cincinnati : University of Cincinnati
Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
Cincinnati : UC Cancer Institute Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Cleveland : University Hospitals of Cleveland
A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab for the Treatment Of Recurrent or Progressive Glioblastoma That Has Progressed on Bevacizumab
Cleveland : Cleveland Clinic
A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab for the Treatment Of Recurrent or Progressive Glioblastoma That Has Progressed on Bevacizumab
View More »
Cleveland : Cleveland Clinic Taussig Cancer Center Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Cleveland : University Hospitals of Cleveland Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Cleveland : Cleveland Clinic Foundation Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Cleveland : Cleveland Clinic Foundation Updated
Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Columbus : Ohio State University Updated
Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Columbus : The Ohio State University - James Comprehensive Cancer Center
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Oregon
Portland : Oregon Health and Sciences University
Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas
Portland : Providence Cancer Center
Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas
Pennsylvania
Danville : Geisinger Health System Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Danville : Geisinger Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Philadelphia : Hospital of the University of Pennsylvania Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Philadelphia : Pennsylvania Hospital Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Pittsburgh : University of Pittsburgh Medical Center (UPMC) Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Rhode Island
Providence : Rhode Island Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
South Carolina
Tennessee
Nashville : Tennessee Oncology
Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Nashville : Sarah Cannon Research Institute
Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma or Progressive Secondary Brain Tumor
Nashville : Vanderbilt Ingram Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Nashville : St. Thomas Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Nashville : Sarah Cannon Research Institute (SCRI) Drug Development Unit
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
View More »
Nashville : Sarah Cannon Research Institute (SCRI)
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Texas
Dallas : Baylor Research Institute
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Dallas : Baylor Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Dallas : Baylor Research Institute Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Dallas : Mary Crowley Cancer Research Centers
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Houston : Methodist Neurological Institute Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
View More »
Houston : Methodist Hospital Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Houston : The University of Texas Health Science Center at Houston (UTHSC) Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Houston : Yvonne Kew, MD, PhD, Neuro-Oncology Clinic Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Houston : UT MD Anderson Cancer Center
Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)
San Antonio : Site Reference ID/Investigator# 90773
A Study Evaluating the Safety and Pharmacokinetics of ABT-414 in Subjects With Glioblastoma Multiforme in Combination With Radiation Plus Temozolomide or Temozolomide Alone
Temple : Scott and White Healthcare Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
The Woodlands : Memorial Hermann The Woodlands Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Virginia
Charlottesville : University of Virginia
Amgen 386 for Recurrent Glioblastoma
Newport News : Peninsula Cancer Institute
Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Richmond : Virginia Cancer Institute
Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Washington
Tacoma : MultiCare Health System
A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
View More »
Seattle : Swedish Neuroscience Institute Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Seattle : Swedish Hospital Neuroscience Research Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Seattle : Swedish Neuroscience Institute Updated
Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Australia
Parkville : Research Site
AMG 595 First-in-Human in Recurrent Gliomas
Austria
Feldkirch : Landeskrankenhaus Feldkirch
Dendritic Cell Cancer Vaccine for High-grade Glioma
Graz : University Hospital Graz Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Innsbruck : Medical University Innsbruck
Dendritic Cell Cancer Vaccine for High-grade Glioma
Linz : Landesnervenklinik Wagner-Jauregg
Dendritic Cell Cancer Vaccine for High-grade Glioma
Vienna : Kaiser Franz-Josef Spital
Dendritic Cell Cancer Vaccine for High-grade Glioma
View More »
Vienna : Medical University Vienna
Dendritic Cell Cancer Vaccine for High-grade Glioma
Vienna : Donauspital, SMZ-Ost
Dendritic Cell Cancer Vaccine for High-grade Glioma
Vienna : SMZ-Süd/Kaiser-Franz-Josef-Spital Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Vienna : Medical University of Vienna Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Canada
Calgary : Tom Baker Cancer Center Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Ottawa : The Ottawa Hospital Cancer Centre Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Czech Republic
Prague : Na Homolce Hospital Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
France
Amiens : CHU Amiens Sud-Salouel Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Angers : CHU Angers Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Bordeaux : Hôpital Saint André Centre Hospitalier Universitaire (CHU) des Hôpitaux de Bordeaux Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Lyon : Hospital of Neurology Lyon - University Claude Bernard Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Paris : Group Hospitals Pitie-Salpetriere Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
View More »
Toulouse : Centre Hospitalo-Universitaire de Toulouse Purpan Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Toulouse Cedex : Institut Claudius Régaud
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Villejuif Cedex : Institut Gustave Roussy, Dept. of Medicine
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Germany
Hamburg : University Medical Center Hamburg-Eppendorf Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Heidelberg : Medical University Heidelberg Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Heidelberg : Department of Neurosurgery, University Hospital Heidelberg
Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.
Heidelberg : University of Heidelberg
Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)
Kiel : University Hospital of Schleswig-Holstein Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Israel
Tel Aviv : Tel Aviv Sourasky Medical Center Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Italy
Ancona : Az. Ospedaliero-Universitaria - Ospedali Riuniti Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Lecco : Ospedale Lecco Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Milan : Foundation Hospital Greater Policlinico Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Milan : C. Besta Neurological Institute Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Rome : Istituti Fisioterapici Ospitalieri - Istituto Nazionale dei Tumori Regina Elena Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Korea, Republic of
Asan : Asan Medical Center Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Daegu : Yeungnam University Hospital Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Daejeon : Chungnam National University Hospital (CNUH) Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Seoul : The Catholic University of Korea, Seoul St. Mary's Hospital (CMC Seoul) Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Seoul : Samsung Medical Center (SMC) Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
View More »
Seoul : Seoul National University Bundang Hospital (SNUBH) Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Seoul : Seoul National University Hospital (SNUH) Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Seoul : Yonsei University Severance Hospital (YUHS) Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Suwon : Ajou University Hospital (AUH) Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Spain
Badalona : Hospital Universitari Germans Trias i Pujol Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Barcelona : Hospital Universitari de Bellvitge-ICO Duran i Reynals Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Barcelona : Hospital Clinic i Provincial de Barcelona Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Barcelona : Hospital del Mar Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Madrid : Fundacion Jimenes Diaz Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
View More »
Madrid : Hospital Clinico San Carlos Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Madrid : Hospital Universitario Ramon y Cajal Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Madrid : Hospital Universitario 12 de Octubre Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Pamplona : Clínica Universidad de Navarra Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Salamanca : Hospital Universitario de Salamanca
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Seville : Servicio de Oncologia Medica Sala de Investigación
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Sweden
Stockholm : Karolinska Institute Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Switzerland
Lausanne : Centre Hospitalier Universitaire Vaudois (CHUV) Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Zurich : UniversitätsSpital Zürich Updated
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
United Kingdom
London : King's College Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer